Validity of a self-reported history of a positive tuberculin skin test: A prospective study of drug users

Journal of General Internal Medicine

Volumn 19, Issue 10, 2004, Pages 1039-1044

  Kunins, Hillary V ^a,b   Howard, Andrea A ^a,b   Klein, Robert S ^a,b   Arnsten, Julia H ^a,b   Litwin, Alain H ^a,b   Schoenbaum, Ellie E ^a,b   Gourevitch, Marc N ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug users; PPD; Tuberculin skin testing; Tuberculosis screening

Indexed keywords

COCAINE; METHADONE; TUBERCULIN;

ADULT; ANAMNESIS; ARTICLE; BULLOUS SKIN DISEASE; CLONAL ANERGY; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SELF REPORT; TUBERCULIN TEST; VALIDATION PROCESS;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SELF DISCLOSURE; SUBSTANCE-RELATED DISORDERS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 7244259223     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2004.30424.x     Document Type: Article

References (25)

1. Geiter L, ed. Ending Neglect: The Elimination of Tuberculosis in the United States. Washington, DC: National Academy Press; 2000.
2. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis. MMWR Recomm Rep. 2000;49:1-51.
3. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320:545-50.
4. Fernandez-Villar A, Sopena B, Vazquez R, et al. Isoniazid hepatoxicity among drug users: the role of hepatitis C. Clin Infect Dis. 2003;36:293-8.
5. Schoenbaum EE, Hartel D, Selwyn PA. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989;321:874-9.
6. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984;252:1905-7.
7. Sokal JE. Measurement of delayed skin-test response. N Engl J Med. 1975;293:501-2.
8. Reichman LB, O'Day R. The influence of a history of a previous test on the prevalence and size of reactions to tuberculin. Am Rev Resp Dis. 1977;115:737-41.
9. Salomon N, Perlman DC, Friedmann P, Ziluck V, Des Jarlais DC. Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program. Int J Tuberc Lung Dis. 2000;4:47-54.
10. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970;26:28-106.
11. Wilson LM. Reversal of the tuberculin reaction: its significant in case finding by survey skin testing. Am Rev Resp Dis. 1970;102:282-4.
12. Fisk TL, Hon H, Lennox JL, von Reyn CF, Horsbrugh CR. Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy (research letter). AIDS. 2003;17:1102-4.
13. Hsu KH. Tuberculin reaction in children treated with isoniazid. Am J Dis Child. 1983;137:1090-2.
14. Perez-Stable EJ, Flaherty D, Schecter G, Slutkin G, Hopewell PC. Conversion and reversion of tuberculin reactions in nursing home residents. Am Rev Resp Dis. 1988;137:801-4.
15. Kunosky S, Katz J. The stability of the tuberculin reaction. Am Rev Tuberc. 1958;78:863-70.
16. Klein RS, Smith D, Sobel J, Flanigan T, Margolick JB, for the HER Study Group. A prospective study of positive tuberculin reactions in women with or at risk for HIV-1 infection. Int J Tuberc Lung Dis. 2000;4:688-92.
17. Tager IB, Kalaidjian R, Baldini L, Rocklin RE. Variability in the intradermal and in vitro lymphocyte responses to PPD in patients receiving isoniazid chemoprophylaxis. Am Rev Respir Dis. 1985;131:214-20.
18. Atuk NO, Hunt EH. Serial tuberculin testing and isoniazid therapy in general hospital employees. JAMA. 1971;218:1795-8.
19. Wolfe H, Marmor M, Maslansky R, et al. Tuberculosis knowledge among New York City injection drug users. Am J Public Health. 1995;85:985-8.
20. Stein MD, Maksad J, Clarke J. Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment. Drug Alcohol Depend. 2001;61:211-5.
21. Straus SM, Rindskopf DM, Deren S, Falkin GP. Concurrence of drug users' self-report of current HIV status and serotest results. J Acquir Immune Defic Syndr. 2001;27:301-7.
22. Howard AA, Klein RS, Schoenbaum EE, Gourevitch MN. Crack cocaine use and other risk factors for tuberculin positivity in drug users. Clin Infect Dis. 2002;35:1183-90.
23. Baldwin BD, Roth MD, Tashkin DP. Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J Neuroimmunol. 1998;83:133-8.
24. Redfield RR, Wright DG, Tramont EC. The Walter Reed staging classification for HTLV-III/LAV infection. N Engl J Med. 1986;314:131-2.
25. Snider DE. The tuberculin skin test. Am Rev Respir Dis. 1982;125:108-18.